Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management
Morie A. Gertz
Hematology
Research output
:
Contribution to journal
›
Article
›
peer-review
25
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Waldenstrom Macroglobulinemia
100%
Risk Management
80%
Bendamustine Hydrochloride
67%
Immunoglobulin M
52%
PCI 32765
43%
Rituximab
31%
carfilzomib
23%
Purine Nucleosides
21%
Monoclonal Gammopathy of Undetermined Significance
20%
Lenalidomide
19%
fludarabine
18%
Everolimus
18%
Thalidomide
18%
Bortezomib
17%
Alkylating Agents
17%
Nucleosides
15%
Stem Cell Transplantation
15%
Lymphadenopathy
15%
Natural History
14%
Disease Management
14%
Platelet Count
14%
Bone Marrow Cells
13%
Thrombocytopenia
13%
Anemia
12%
Lymphoma
12%
Hemoglobins
11%
Poisons
10%
Proteins
10%
Therapeutics
9%
Mutation
8%